Transactions
POZEN licensed the U.S. marketing rights for MT-300 to Xcel Pharmaceuticals
Sep. 2003
Client: Pozen is a pharmaceutical development company
Role: Edgemont Partners acted as exclusive financial advisor to POZEN in the partnering of its exclusive rights to MT-300 to Xcel Pharmaceuticals
Location: Chapel Hill, NC
Sector: Pharmaceutical Services
Lead Banker: David Blume
licensed the U.S. marketing rights for MT-300 to
